ArticlePlant biotechnology journal2026
Multiplexed Engineering of Disease Resistance and Lodging Tolerance in Wheat Via a Single Xylan Modifying Glycosyltransferase.
Article in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Breeding crops with robust disease resistance often compromises yield, a persistent challenge in agricultural improvement. We report that modifying cell wall architecture through a xylan-specific glycosyltransferase successfully breaks this trade-off in wheat. TaXAX1, a pathogen-induced member of the glycosyltransferase (GT)61 family, catalyses arabinose modification of xylan and is predominantly localized to the Golgi apparatus. CRISPR/Cas9 knockout mutants of Taxax1 exhibited enhanced susceptibility to three major fungal diseases: Fusarium head blight (FHB), Fusarium crown rot (FCR) and stripe rust. Conversely, overexpression of TaXAX1 significantly enhanced resistance to all three pathogens concurrently. Remarkably, this multi-disease resistance was achieved without any reduction in grain yield. Mechanistically, TaXAX1 mediates cell wall fortification by increasing xylan arabinose modification arabinosylation, upregulating the phenylpropanoid pathway and enhancing the deposition of lignin, cellulose and phenolic cross-linkers. This resulted in a thicker and more reinforced secondary cell wall, which also translated into superior stem strength. Our study identifies TaXAX1 as a master regulator of cell wall remodelling and provides a compelling strategy for designing wheat varieties with integrated resilience against multiple diseases and environmental stresses, while safeguarding yield potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.